BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.82
0.32%
US Tech 100
20,240.00
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.40053
-0.02%
Bitcoin
95,616.34
-0.04%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Ipsen SA (IPN) Share Price

Ipsen SA

Ipsen SA (IPN)

EU
109.50
0.00
(0.00%)
Closed November 28 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
109.50
Bid
109.50
Ask
110.10
Volume
25,011
109.50 Day's Range 110.30
99.70 52 Week Range 126.70
Market Cap
8.982B
Previous Close
109.50
Open
109.60
Last Trade
4
@
109.5
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
62,705
Shares Outstanding
82,029,421
Dividend Yield
1.10%
PE Ratio
13.94
Earnings Per Share (EPS)
7.86
Revenue
3.37B
Net Profit
644.4M

About Ipsen SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ipsen.com
Headquarters
Boulogne-billancourt, Hauts-de-seine, Fra
Founded
-
Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 109.50 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 126.70 €.

Ipsen currently has 82,029,421 shares outstanding. The market capitalization of Ipsen is 8.98 € billion. Ipsen has a price to earnings ratio (PE ratio) of 13.94.

Ask ADVFN Intelligence (AI)

IPN Latest News

More News

Bylvay® (odévixibat) montre une amélioration soutenue en termes de sévérité des démangeaisons et de taux d’acides biliaires sériques chez les patients atteints de CIFP et du SAG

Bylvay® (odévixibat) montre une amélioration soutenue en termes de sévérité des démangeaisons et de taux d’acides biliaires sériques chez les patients atteints de CIFP et du SAG Ipsen met en avant...

November 18 2024
UK Regulatory

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS Ipsen presents 3 late-breaking presentations and 8 abstracts across...

November 18 2024
UK Regulatory

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024 PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today...

November 18 2024
GlobeNewswire Inc.

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus Ipsen presents 3 late-breaking presentations and 8 abstracts...

November 15 2024
UK Regulatory

Iqirvo® (elafibranor) montre des données d’efficacité et de tolérance sur une période allant jusqu’à trois ans chez les patients atteints de CBP avec une amélioration de la fatigue et du prurit

Iqirvo® (elafibranor) montre des données d’efficacité et de tolérance sur une période allant jusqu’à trois ans chez les patients atteints de CBP avec une amélioration de la fatigue et du prurit...

November 15 2024
UK Regulatory

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September...

November 15 2024
GlobeNewswire Inc.

Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de...

November 07 2024
UK Regulatory

Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights...

November 07 2024
UK Regulatory

Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance

Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance PARIS, FRANCE, 23 October 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global...

October 23 2024
UK Regulatory

Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance

PARIS, FRANCE, 23 October 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its performance for the year to date and the third quarter of...

October 23 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.81.6713091922107.7111.510778683110.3211416DE
4-3.1-2.75310834813112.6113.7105.563228110.00895688DE
120.30.274725274725109.2117.5104.662705111.01541553DE
26-11.6-9.57886044591121.1126.7100.368708111.69502899DE
526.66.4139941691102.9126.799.771795109.64050259DE
15620.7223.338589772588.78130.77780707104.20839387DE
2604.34.08745247148105.2130.734.210296288.66061812DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALKALKALRAY SA
2.16 €
(109.71%)
948k
ALEUPEuroplasma
0.115 €
(86.99%)
15.44M
ALNEVNeovacs
0.0003 €
(50.00%)
225.63M
ALSPWSpineway
0.1191 €
(45.60%)
7.98M
RWIRenewi Plc
9.54 €
(42.39%)
1.55M
GJAJGroupe Jaj
0.60 €
(-43.93%)
300
ALIMOGroupimo
0.189 €
(-30.51%)
53
ALDVAlliance Developpement Capital Siic
0.056 €
(-24.32%)
62
ATOAtos SE
0.7814 €
(-22.86%)
42.95M
MLAATAzorean Tech
0.095 €
(-20.83%)
300
ALNEVNeovacs
0.0003 €
(50.00%)
225.63M
ALHPIHopium SA
0.0091 €
(0.00%)
93.28M
ATOAtos SE
0.7814 €
(-22.86%)
42.95M
BCPBanco Comercial Portugues SA
0.4468 €
(0.63%)
38.07M
ALDRVDrone Volt
0.0037 €
(2.78%)
21.94M

Discussion

View Full Feed
delerious1 delerious1 4 minutes ago
yes absolutely....so glad I picked up a bundle of NBRI...and so glad for the updates from all areas....where else could anyone get that sense of security
NBRI
rooster rooster 4 minutes ago
https://x.com/onefinejay/status/1861949925547819018?s=46&t=qLQnO1TjeygtFbhEqQdlmg
janice shell janice shell 4 minutes ago
No, I did not. Slept all day. Still have the sore throat...
Money hunt Money hunt 5 minutes ago
So I thought I would try some Dana graphics on ELAB, but I couldn't find any relative to what I was looking for. I kept getting an error saying there is no Dana...
Only Zuul.
Smile folks...It's about time to head to brighter horizons into blue skies$$$
ELAB
OTCShotCaller OTCShotCaller 5 minutes ago
You NAILED it real good! See my above post....I mention the EXACT same thing among other highly important matters that place CYBL way ahead of the pack!

Best Wishes!
CYBL
rooster rooster 5 minutes ago
https://x.com/realdonaldtrump/status/1862281187600793830?s=46&t=qLQnO1TjeygtFbhEqQdlmg
Tadaaa Tadaaa 6 minutes ago
Yup, Weekly and Monthly, Daily just hit the Golden Cross
HBARUSD
3331 3331 7 minutes ago
Your "guarantee" means absolutely nothing chump.
Penny Hopeful Penny Hopeful 8 minutes ago
hurry, hurry, hurry
SMME has been such a resounding success that she is at it gain over at Smart Biometric Technologies
Don't mis your opportunity ?????


PATENTS ISSUED -

PRE PRODUCT RELEASE INVESTMENT OPPPORTUNITY

A FUND RAISING ROU
SMME
janice shell janice shell 10 minutes ago
As a matter of fact, several of the tickers that had the buy button turned off a few years ago have recently become current and have experienced a price and volume surge.

And which ones would those be? Got some specific examples?

This ticker is no different.
CRGP
MRc2 MRc2 10 minutes ago
Who let you out. I do hope you had a good Thanksgiving Mr. Crumb. now as for Triller... word is more TT folks headed into the company with Mr. Km coming aboard.. Now are you going to say Sean Kim is a idiot for coming into ILLR . ... Mr. Crumb rumor is a lot of press on its way. Nice try though..
ILLR
ironhammer ironhammer 13 minutes ago
i agree Del a lot of good things comming
NBRI
MartinLutherKing MartinLutherKing 14 minutes ago
Suspect tomorrow will be the beginning of a multi day squeeze. I will be going in heavily on this one
ELAB
pennyonfire pennyonfire 14 minutes ago
The Santa Claus rally starts tomorrow
AZRH
Koog Koog 15 minutes ago
Could you possibly be more succinct?
BIEL
OTCShotCaller OTCShotCaller 15 minutes ago
We've entered "The Rise of The Drone Age" which is rapidly gaining momentum! The Elon Musk & Trump Years mark the rise of the Drone Age, let there be no doubt about it!

Not only are drones required in the new age of global warfare, they have expanded applications like U.S. border sec
CYBL UMAC
delerious1 delerious1 17 minutes ago
So as we see in the re-cap of the latest develpoments with the Mill and 3 mines....NBRI it would show that things are goin' great....and they're only gettin' better...doin' all right...gettin' good grades....the future's so bright...we gotta wear shades
NBRI
MartinLutherKing MartinLutherKing 17 minutes ago
$3 News coming tomorrow morning brother stay tuned P/M
RNAZ
STILL TOWING STILL TOWING 18 minutes ago
lol, nope it sure didn't.. I sure hope it gets reposted.. I hope it's about fiduciary duties..someone can send it to the beggar looking for money to file..SMH
MRGE
skitahoe skitahoe 19 minutes ago
When people anywhere ask me questions, I answer. I'm happy to discuss it on the NWBO board, but don't limit myself to that.

Gary
NWBO
Buellersback Buellersback 19 minutes ago
🙄...
RGLG
delerious1 delerious1 23 minutes ago
Wow nice way to partner up....and with the nextgen electrolyzers price per kilo is coming down....let's hope PLUG keeps up with new developments
slops slops 24 minutes ago
I look for heavy volume.
VDRM
williamssc williamssc 25 minutes ago
Some Shkreli fallout? It's old and tired.
AVXL
slops slops 26 minutes ago
Open untill 1:00 tomorrow fri.
VDRM

Your Recent History

EU
IPN
Ipsen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49